Skip to content

Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy

Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07041710
Acronym
AGORA
Enrollment
104
Registered
2025-06-27
Start date
2022-08-16
Completion date
2027-07-30
Last updated
2025-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Changes in taste and smell can occur during chemotherapy treatment. These chemotherapy-related side effects can negatively impact patients' quality of life and diet. The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.

Interventions

OTHERexperimental in day hospital

multidisciplinary day hospital

OTHERtaste and smell disorders questionnaire

Answer to the home-made questionnaire at inclusion and at 6 months

Sponsors

Médipôle Lyon-Villeurbanne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cancer treated with chemotherapy * patient with taste and/or smell disorders

Exclusion criteria

* patient at the end of chemotherapy treatment

Design outcomes

Primary

MeasureTime frameDescription
difference in scores between 6 months and the inclusion at taste and smell disorders questionnaire6 monthstaste and smell disorders home-made questionnaire (score from 0 to 100)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026